Find Distrontium Renelate Octahydrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Distrontium renelate octahydrate, 674773-15-0, 8pd4806e06, Strontium ranelate, 3-thiopheneacetic acid, 5-(bis(carboxymethyl)amino)-2-carboxy-4-cyano-, strontium salt (1:2), octahydrate, Unii-8pd4806e06
Molecular Formula
C12H22N2O16SSr2
Molecular Weight
657.6  g/mol
InChI Key
ZHEZAQJNZMLYBA-UHFFFAOYSA-J
FDA UNII
8PD4806E06

Distrontium Renelate Octahydrate
1 2D Structure

Distrontium Renelate Octahydrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate;octahydrate
2.1.2 InChI
InChI=1S/C12H10N2O8S.8H2O.2Sr/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20;;;;;;;;;;/h1,3-4H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22);8*1H2;;/q;;;;;;;;;2*+2/p-4
2.1.3 InChI Key
ZHEZAQJNZMLYBA-UHFFFAOYSA-J
2.1.4 Canonical SMILES
C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-].O.O.O.O.O.O.O.O.[Sr+2].[Sr+2]
2.2 Other Identifiers
2.2.1 UNII
8PD4806E06
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic Distrontium Salt

2. Protelos

3. S 12911

4. S-12911

5. S12911

6. S12911-0

7. S12911-2

8. S12911-5

9. Strontium Ranelate

2.3.2 Depositor-Supplied Synonyms

1. Distrontium Renelate Octahydrate

2. 674773-15-0

3. 8pd4806e06

4. Strontium Ranelate

5. 3-thiopheneacetic Acid, 5-(bis(carboxymethyl)amino)-2-carboxy-4-cyano-, Strontium Salt (1:2), Octahydrate

6. Unii-8pd4806e06

7. Dtxsid00217833

8. Q27270857

2.4 Create Date
2013-04-19
3 Chemical and Physical Properties
Molecular Weight 657.6 g/mol
Molecular Formula C12H22N2O16SSr2
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count19
Rotatable Bond Count4
Exact Mass657.8802283 g/mol
Monoisotopic Mass657.8802283 g/mol
Topological Polar Surface Area224 Ų
Heavy Atom Count33
Formal Charge0
Complexity533
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count11
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Bone Density Conservation Agents

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty